Re:Covid vaccine: First ‘milestone’ vaccine offers 90% prote...
by bipson on Monday November 09, 2020 @08:39AM
(#25034661)
In particular BioNTech from the article was founded 2008. This is their first publicly available "product" - it applies their vision for cancer treatment to specific SARS-nCoV-2 proteins (arguably I don't know if they're working on other ideas as well).
They might be working on this particular vaccine since 2020, but AFAIK they have been working on the specific principle the vaccine uses since 2008.
Yes, I first heard about intramuscular nucleic acid injection around the year 2000. At the time it was naked DNA and not RNA in a lipid nanoparticle suspension, but the principle was the same.